HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

925.261

-17.354-1.84%

Number of Gainers:1

Number of Losers:15

Number of Flat:1

PE:- -

High:953.957

Open:948.880

Low:922.369

Close:942.615

Volume:319.68M

Turnover:2.68B

Market Cap:624.69B

Float Cap:518.12B

Loading ...

Junshi Biosciences Shareholder Cuts Stake

MT Newswires Live

JUNSHI BIO Shareholder He Ming Completes Sale of 882,600 Shares, Fulfilling Reduction Plan

Ascletis Pharma Begins Obesity Drug Candidate Trial

MT Newswires Live

Gold Jewelry Leads Consumer Recovery, AI-Driven Healthcare Continues Strong Momentum

CSPC Pharmaceutical's Mpox Vaccine Candidate Gets Trial Approval from US FDA

MT Newswires Live

Market Trends Consolidate: Multiple Healthcare Stocks Display 'Pair' Patterns, Here's What It Could Mean

CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine

Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: Asc36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and Asc36_35Fdc Once-Monthly Injection, a Co-Formulation of Asc36 and Glp-1R/Gipr Peptide Agonist Asc35

THOMSON REUTERS

CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine

CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.

THOMSON REUTERS

Ascletis-B Launches Two Phase 1 Obesity Studies in the United States

Ascletis Pharma - U.S. FDA Clears Ind Applications for Asc36 and Asc36_35Fdc

THOMSON REUTERS

Ascletis Says FDA Clears INDs for Obesity Candidates Asc36, Asc36_35fdc

Record-Breaking Surge: WuXi Apptec Sets New Benchmarks, Reviving the Innovative Drug Sector’s Momentum? A New QDII Fund Launches to Capture the Opportunity

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

BYD Electronic (International) Stock Climbs 1.8% in Hong Kong

Alibaba Health Information Technology Stock Climbs 2.2% in Hong Kong

JD Health International Stock Advances 2.9% in Hong Kong

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1515/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":925.26135,"timestamp":1787553535037,"preClose":942.61523,"halted":0,"volume":319680109,"delay":0,"changeRate":-0.01841,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-17.353882,"latestTime":"08-24 14:38:56","open":948.8799,"high":953.9568,"low":922.3685,"amount":2678167175,"amplitude":0.033511,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787559000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"pbRate":1.422618,"peRate":17.199147,"turnoverRate":0.004378,"increases":1,"decrements":15,"flats":1,"marketCap":624689520576,"floatMarketCap":518116070848},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":953.9568,"amplitude":0.033511,"preClose":942.61523,"low":922.3685,"pbRate":"1.422618","latestPrice":925.26135,"volume":319680109,"delay":0,"open":948.8799,"prevYearClose":1190.107,"prevWeekClose":942.615,"prevMonthClose":925.972,"prevQuarterClose":802.777,"fiveDayClose":915.795,"twentyDayClose":908.671,"sixtyDayClose":923.442,"secType":"PLATE","market":"HK","turnoverRate":0.004378,"peRate":17.199147,"marketCap":624689520576,"floatMarketCap":518116070848,"timestamp":1787553535037,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":1,"down":15,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658963170","title":"Junshi Biosciences Shareholder Cuts Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2658963170","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658963170?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:17","pubTimestamp":1786411021,"startTime":"0","endTime":"0","summary":"Shanghai Junshi Biosciences'  shareholder, He Ming, sold 882,600 shares for 33.5 million yuan, according to a Tuesday filing.The shares were sold through centralized bidding at prices ranging from 35.76 yuan to 40.34 yuan each between July 3 and Aug. 10.Following the sale, He Ming held 2.65 million shares, or 0.2579% of the company's total share capital, down from 0.3440%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01877","FCA","BK1515","BK1161","BK0239","688180","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149534914","title":"JUNSHI BIO Shareholder He Ming Completes Sale of 882,600 Shares, Fulfilling Reduction Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1149534914","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149534914?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:10","pubTimestamp":1786367411,"startTime":"0","endTime":"0","summary":"JUNSHI BIO (01877) has announced that it recently received a notice from Ms. He Ming regarding the results of her share reduction. Ms. He Ming's planned reduction has been fully executed, with a total of 882,600 shares sold, amounting to approximately 33.54 million yuan.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01877","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658193554","title":"Ascletis Pharma Begins Obesity Drug Candidate Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658193554","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658193554?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:55","pubTimestamp":1786362947,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (HKG:1672) initiated two phase I studies in the U.S. for ASC36 and ASC36_35FDC for the treatment of obesity.The move comes following investigational new drug clearance by the U.S. Food and Drug Administration (FDA), according to a Monday Hong Kong bourse filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1574","01672","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160532640","title":"Gold Jewelry Leads Consumer Recovery, AI-Driven Healthcare Continues Strong Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1160532640","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160532640?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:50","pubTimestamp":1786362646,"startTime":"0","endTime":"0","summary":"Despite the massive subscription for Unitree Technology shares today, the market remained unaffected, with Hong Kong stocks jumping 1.05% at the open. With the midterm elections approaching, the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU0348766576.USD","LU0390135688.USD","BK1103","BK1535","BK1161","LU0314109678.HKD","SG9999001093.SGD","09939","LU0593848301.USD","VXUS","LU1242518857.USD","SGXZ90724238.SGD","BK1544","LU1242518931.SGD","KCAI","BK1198","LU0300738514.USD","LU1813983027.USD","VTHR","LU0300738605.USD","LU0463099449.HKD","LU0348767384.USD","LU2279858448.HKD","BK1227","LU2543165471.USD","QTOC","BK1237","LU0390135506.SGD","BK4585","SG9999001051.SGD","BK1574","SGXZ86797644.SGD","SG9999003461.SGD","LU0244354667.USD","09858","02419","BK4588","HK0000500386.USD","CHAT","BK1515","ARTY","02714","LU2039709279.SGD","LU2213484517.USD","SG9999002950.SGD","LU1188198961.HKD","LU0049112450.USD","SG9999011746.SGD","LU1235295612.USD","LU1046422090.SGD","02259","HK0000252152.HKD","LU0390135332.USD","159938","BK1587","HK0000252160.HKD","AGIX","LU0979878070.USD","02343","LU1171460220.USD","LU1328277881.USD","AIPO","SGXZ62798434.SGD","BK1212","06181"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933761","title":"CSPC Pharmaceutical's Mpox Vaccine Candidate Gets Trial Approval from US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933761","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933761?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:40","pubTimestamp":1786362027,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical's  SYS6037 Injection obtained approval from the U.S. Food and Drug Administration  to conduct clinical trials in the U.S.The mpox vaccine was co-developed by the company and the Institute of Microbiology, the Chinese Academy of Sciences, according to a Monday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2039709279.SGD","LU1993786604.SGD","HK0000165453.HKD","LABU","LU1152091754.HKD","LU1328277881.USD","IE00BZ08YT58.USD","KURE","LU1807302812.USD","LU1152091168.USD","SG9999004220.SGD","BK1515","LU0326950275.SGD","LU0072913022.USD","LU0315179316.USD","LU0140636845.USD","LU1226288253.USD","LU1226287529.USD","BK1191","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU0501845795.SGD","IE00B543WZ88.USD","LU1813983027.USD","IE0008369823.USD","LU1226287875.USD","IE00BZ08YS42.EUR","LU0067412154.USD","LU1960683339.HKD","LU1226288170.HKD","BK4585","BK4588","01093","BK1521","IE0008368742.USD","LU0314109678.HKD","IE00B5MMRT66.SGD","LU0880133367.SGD","LU1008478684.HKD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144690241","title":"Market Trends Consolidate: Multiple Healthcare Stocks Display 'Pair' Patterns, Here's What It Could Mean","url":"https://stock-news.laohu8.com/highlight/detail?id=1144690241","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144690241?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:21","pubTimestamp":1786360885,"startTime":"0","endTime":"0","summary":"Today, the three major A-share indices ended with mixed results, with the Shanghai Composite Index marking its fifth consecutive daily gain. At the close, the Shanghai Composite Index and the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182339913","title":"CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1182339913","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182339913?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:02","pubTimestamp":1786359759,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) announced that its investigational new drug, SYS 6037 injection (monkeypox mRNA vaccine), a Class 1 preventive biological product developed in collaboration with the Institute of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","IE00B5MMRT66.SGD","KURE","IE00BZ08YR35.GBP","LU0501845795.SGD","BK4139","LU1226287875.USD","BK4505","LU1226288170.HKD","LU1226288253.USD","01093","IBBJ","IE00BZ08YT58.USD","159646","LU1960683339.HKD","LU1008478684.HKD","IE00BZ08YS42.EUR","BK1191","BK1521","LU1152091754.HKD","LU0067412154.USD","IBBQ","LU1813983027.USD","LU1951186391.HKD","BMED","LU1807302812.USD","LU0072913022.USD","IE0008369823.USD","RNA","BK4585","LU0140636845.USD","LU1993786604.SGD","LU0314109678.HKD","LU1152091168.USD","LU1328277881.USD","PSYK","LU2039709279.SGD","HK0000165453.HKD","LU1226287792.SGD","IE0008368742.USD","LU0326950275.SGD","BK4588","IE0009354923.USD","BK1515","SG9999004220.SGD","IE00B543WZ88.USD","LU0880133367.SGD","LU0315179316.USD","LU1226287529.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980079","title":"Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: Asc36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and Asc36_35Fdc Once-Monthly Injection, a Co-Formulation of Asc36 and Glp-1R/Gipr Peptide Agonist Asc35","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980079?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359615,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470PG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1515","01672","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658270980","title":"CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2658270980","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658270980?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:58","pubTimestamp":1786359481,"startTime":"0","endTime":"0","summary":"CSPC says FDA clears US clinical trial for SYS 6037 mpox mRNA vaccineCSPC’s SYS 6037 injection, an mRNA monkeypox vaccine co-developed with the Chinese Academy of Sciences’ Institute of Microbiology, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL4XF0Px:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0140636845.USD","LU0880133367.SGD","LU0326950275.SGD","LU0067412154.USD","LU1226287529.USD","BK1515","LU1813983027.USD","LU0315179316.USD","LU1226288253.USD","LU1226287792.SGD","LU1008478684.HKD","LU1951186391.HKD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","SG9999004220.SGD","KURE","IE00B031HY20.USD","BK1521","LU1807302812.USD","IE00B543WZ88.USD","LU0072913022.USD","LU1328277881.USD","LU2039709279.SGD","LU1152091168.USD","HK0000165453.HKD","IE00BZ08YR35.GBP","LU1993786604.SGD","LU0314109678.HKD","BK1191","IE0008369823.USD","LU0501845795.SGD","LU1152091754.HKD","01093","LU1960683339.HKD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980216","title":"CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980216?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:57","pubTimestamp":1786359457,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0314109678.HKD","LU1226287792.SGD","LU1226287875.USD","LU1813983027.USD","LU1008478684.HKD","01093","LU1152091168.USD","IE0008368742.USD","IE00B5MMRT66.SGD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU1226288170.HKD","IE0008369823.USD","IE00B031HY20.USD","LU0326950275.SGD","SG9999004220.SGD","LU1807302812.USD","LU1993786604.SGD","BK1191","LU1226287529.USD","IE00BZ08YR35.GBP","LU0067412154.USD","LU1226288253.USD","LU1328277881.USD","LU1951186391.HKD","HK0000165453.HKD","LU0880133367.SGD","BK1521","KURE","IE00B543WZ88.USD","LU1152091754.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK1515","LU0140636845.USD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159859212","title":"Ascletis-B Launches Two Phase 1 Obesity Studies in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=1159859212","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159859212?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:57","pubTimestamp":1786359439,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) has announced that, following Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA), it has initiated two Phase 1 studies in the United...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","BK1515","01477","BK1161","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658198045","title":"Ascletis Pharma - U.S. FDA Clears Ind Applications for Asc36 and Asc36_35Fdc","url":"https://stock-news.laohu8.com/highlight/detail?id=2658198045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658198045?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:50","pubTimestamp":1786359050,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470MZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","01672","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658801059","title":"Ascletis Says FDA Clears INDs for Obesity Candidates Asc36, Asc36_35fdc","url":"https://stock-news.laohu8.com/highlight/detail?id=2658801059","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658801059?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:50","pubTimestamp":1786359049,"startTime":"0","endTime":"0","summary":"Ascletis says FDA clears INDs for obesity candidates ASC36, ASC36_35FDCAscletis received US FDA IND clearance to start two Phase 1 obesity studies of ASC36 and monthly fixed-dose combo ASC36_35FDC.Tri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL55q8X6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","01672","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160559566","title":"Record-Breaking Surge: WuXi Apptec Sets New Benchmarks, Reviving the Innovative Drug Sector’s Momentum? A New QDII Fund Launches to Capture the Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=1160559566","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160559566?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:36","pubTimestamp":1786358172,"startTime":"0","endTime":"0","summary":"The pharmaceutical sector was jolted awake in early August by a stunning half-year earnings report. The company posted a revenue of 288.97 billion yuan, a 38.93% year-on-year increase, and a net...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","IE00BPRC5H50.USD","LU1770034418.SGD","09939","LU1251922891.USD","LU1808992512.USD","LU1997245094.SGD","LU0708995583.HKD","LU1969619763.USD","LU1997245177.USD","BK0216","LU1979443071.USD","LU2045819591.USD","LU0052750758.USD","LU1303224171.USD","LU1719994722.HKD","LU2242644610.SGD","LU2488822045.USD","06978","LU1934453819.USD","LU0348766576.USD","BK1583","BK1515","LU0700851271.USD","MEDX","LU0456842615.SGD","02359","LU2125910500.SGD","BK1576","LU1997244956.HKD","BK1141","LU0320764599.SGD","LU0611395673.USD","603259","LU0348767384.USD","LU2495084118.USD","LU2328871848.SGD","LNGR","159938","IBBQ","IE00B5MMRT66.SGD","LU1046422090.SGD","IE00B543WZ88.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658891989","title":"Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658891989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658891989?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:33","pubTimestamp":1786350780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 0.9% to 5.05 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25937.49.The stock's fall snapped a two-day winning streak.Sino Biopharmaceutical Ltd. closed 45% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.7% and Amgen Inc. remained unchanged.Trading volume totaled 86.6 million shares, compared to the 50-day average of 101.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","LU1983299246.USD","BBH","BK1191","LU2242652126.USD","IBBQ","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","BK4533","LU2242646821.SGD","AMGN","SG9999001440.SGD","BK1515","IE00BZ08YS42.EUR","HK0000165453.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","IBB","LU0868494617.USD","01177","BK4585","LU1057294990.SGD","LU2112291526.USD","PBE","BK1521","IE00BZ08YT58.USD","BK4139","LU2089984988.USD","LU0289739699.SGD","IE00B2B36J28.USD","BIB","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","PJP","LU0058720904.USD","LU2468319806.SGD","BK4588","LU0109394709.USD","BK4534","BK1589","BK4599","IE00BZ08YR35.GBP","LU1023059063.AUD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658197989","title":"BYD Electronic (International) Stock Climbs 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2658197989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658197989?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:32","pubTimestamp":1786350720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. rallied 1.8% to 24.36 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25937.49.The stock's rise snapped a two-day losing streak.BYD Electronic  Co. Ltd. closed 48% below its 52-week high of HK$46.70, which the company achieved Sept. 2.The stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. rose 0.5%.Trading volume totaled 5.9 million shares, compared to the 50-day average of 13.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1504","00285","BK1582","BK1607","BK1580","BK1149","BK1589","LU0274383008.USD","BK1540","LU0348767384.USD","BK1167","LU0348766576.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658160989","title":"Alibaba Health Information Technology Stock Climbs 2.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2658160989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658160989?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:32","pubTimestamp":1786350720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. rose 2.2% to 3.66 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25937.49.This was the stock's second consecutive day of gains.Alibaba Health Information Technology Ltd. closed 54% short of its 52-week high of HK$7.91, which the company achieved Jan. 14.The stock outperformed some of its competitors, as HKT Trust & HKT Ltd. fell 1.2%.Trading volume totaled 86.0 million shares, compared to the 50-day average of 115.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09115","BK1502","HHImain","BK1501","BK1591","BK1515","07300","BK1247","BK1142","BK1615","HK0000165453.HKD","BK1617","82800","07500","00241","BK1571","HSI","MCHmain","07200","BK1610","BK1189","83115","HSTECH","MHImain","02800","02833","513600","BK1584","BK1589","03115","03419","03037"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658989926","title":"JD Health International Stock Advances 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2658989926","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658989926?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:30","pubTimestamp":1786350600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. rallied 2.9% to 40.08 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25937.49.The stock's rise snapped a two-day losing streak.JD Health International Inc. closed 44% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 9.0 million shares, compared to the 50-day average of 10.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","07200","82800","BK1589","LU0051755006.USD","02833","SGXZ62798434.SGD","BK1615","513600","07500","HSI","09115","BK1591","02800","LU0456827905.SGD","HHImain","BK1142","06618","BK1571","BK1583","BK1247","07300","83115","03037","03419","86618","MCHmain","03115","MHImain","HSTECH","SGXZ86797644.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":11,"totalSize":218,"code":"91000000","status":"200"}]}}